Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Fortis shareholders...

    Fortis shareholders give approval for stake sale to IHH

    Written by Ruby Khatun Khatun Published On 2018-08-16T16:38:25+05:30  |  Updated On 16 Aug 2018 4:38 PM IST
    Fortis shareholders give approval for stake sale to IHH

    New Delhi: Fortis Healthcare said its shareholders have given nod to the acquisition of the domestic healthcare chain by Malaysia's IHH Healthcare.


    The shareholders of Fortis Healthcare have by an overwhelming majority of 99.69 percent voted in favour of the issuance of equity shares on a preferential allotment basis.


    They have also approved by 99.99 percent votes to reclassify members of promoter/promoter group to public shareholder category and classification of Northern TK Venture Pvt Ltd as a promoter.



    Earlier, in a notice for the EGM in July, Fortis Healthcare had said that the consent of shareholders is being sought for issuance of 23,52,94,117 equity shares on preferential basis at a price of Rs 170 per share aggregating up to Rs 4,000 crore to Northern TK Venture Pte Ltd.

    The company had also sought nod from shareholders to reclassify Malvinder Mohan Singh; Malvinder Mohan Singh - Trust; Shivinder Mohan Singh; Harpal Singh, Abhishek Singh; Fortis Healthcare Holdings Pvt Ltd; Malav Holdings Pvt Ltd and RHC Holding Pvt Ltd from the 'Promoter and Promoter Group' shareholder category to 'Public' shareholder category.


    It had asked shareholders to approve classification of Northern TK Venture Pte Ltd as 'Promoter' subsequent to the completion of the preferential allotment of equity shares.


    On July 13, the Fortis Healthcare board had approved an Rs 4,000-crore offer from IHH Healthcare for 31.1 percent stake in it, valuing the cash-strapped firm at Rs 8,880 crore.


    The transaction, to be carried out via IHH Healthcare's arm Northern TK Venture Pte Ltd, was to be followed up by an open offer for an additional 26 percent stake in Fortis.


    IHH Healthcare is expected to shell out a total of Rs 7,300 crore to acquire 57.1 percent stake, provided its open offer for 26 percent stake is fully subscribed.


    The deal is expected to bring relief to the cash-strapped Fortis. It is reported that the company Fortis posted a net loss of 707.4 million rupees ($10 million) for the three months ended June 30 and has now been in the red for five of the last six quarters, as it struggled with a cash crunch, rising debt, and other problems.

    However, it said occupancy rates at its hospitals had risen to over 69 percent currently, from 62 percent in the quarter through June.


    The first quarter loss reversed a 52.9 million rupee profit in the same period a year earlier, and income from operations fell 9.9 percent in the first quarter from a year earlier to 10.4 billion rupees.


    “...The last quarter performance has been impacted severely due to the continuing challenges that the company had been facing over the last 18 months that have led to liquidity issues,” Chief Executive Bhavdeep Singh said in a statement.


    The company said it aims to reach average occupancy levels for its hospital business of over 70 percent by the fourth quarter of fiscal 2019.

    approvalBhavdeep SinghEGMfirst quarterFortisFortis HealthcareHarpal SinghIHHIHH HealthcareMalvinder Mohan Singhnet losspreferential allotmentRHC Holding Pvt LtdshareholdersShivinder Mohan Singhstake saleTK Venture Pvt Ltd
    Source : With Agency Inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok